Particularly, Faheim M. et al revealed that miR-144 was downregulated in GC cells, and miR-144 could inhibit GC cell proliferation and invasion by directly targeting activating enhancer-binding protein 4 (AP4) [26]. The gene discussed is TFAP4; the disease is gastric cancer.